CTOs on the Move

Outcome Resources

www.outcomeresources.com

 
Outcome Resources is a Rocklin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

KOMET USA

KOMET USA is a Rock Hill, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Plus Management

Health Plus Management Services, LLC (“Health Plus”) provides the most effective solutions for physicians who wish to outsource their practice`s non-medical functions. Our experienced and knowledgeable employees manage the daily non-medical operations for independently-owned physician practices throughout New York. Through a variety of marketing and advertising initiatives, we also raise awareness of our clients` practices and the field of physical medicine and rehabilitation. We provide our services strictly to physicians who are dedicated to providing high quality care.

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.

Outpatient Imaging

Outpatient Imaging is a medical imaging center that offers a variety of diagnostic tests and procedures. Patients have the power to choose which imaging center performs their exam, as mandated by law in Georgia.

Wolters Kluwer Clinical Drug Information

Wolters Kluwer Clinical Drug Information connects you to the information and technology you need to strengthen medication decision making.